


                                                                    Exhibit 99.1


FRANKLIN CAPITAL CORPORATION
100 WILSHIRE BOULEVARD, 15TH FLOOR, SUITE 1500
SANTA MONICA, CALIFORNIA 90401
(310) 752-1416

FOR IMMEDIATE RELEASE

                          FRANKLIN CAPITAL CORPORATION
                  COMPLETES FOURTH CLOSING OF PRIVATE PLACEMENT

        SANTA  MONICA,   CALIFORNIA,   December  22,  2004  -  Franklin  Capital
Corporation (AMEX: FKL) (the "Company") announced today that, as a result of the
Company's receipt of additional  proceeds in connection with a fourth closing of
the Company's  previously  announced  private  placement of shares of its common
stock and  warrants  to  purchase  additional  shares of its common  stock,  the
Company has received to date aggregate  proceeds of  approximately  $4.0 million
from the private  placement.  These proceeds will be used in connection with the
Company's   previously  announced   restructuring  and  recapitalization   plan,
including to expedite the Company's entry into the medical  products/health care
solutions industry and financial services industry.

          The shares of common stock and warrants to purchase  additional shares
of common stock issued in connection  with the private  placement  have not been
registered under the Securities Act of 1933, as amended,  and may not be offered
or sold  unless  they are so  registered  or are  exempt  from the  registration
requirements.

FORWARD-LOOKING STATEMENTS

This  press  release  contains  certain  forward-looking  statements  within the
meaning of Section 27A of the  Securities  Act of 1933, as amended,  and Section
21E of the  Securities  Exchange Act of 1934, as amended,  including  statements
regarding  the future  plans and  intentions  of the  Company.  Examples of such
statements include,  without  limitation,  statements relating to the use of the
proceeds from the private placement in connection with the Company's  previously
announced restructuring and recapitalization plan and its entry into the medical
products/health care solutions industry and financial services industry. Readers
are cautioned that these  forward-looking  statements are predictions based only
on current information and expectations that are inherently subject to risks and
uncertainties  that could cause  future  events or results to differ  materially
from those set forth or implied by the forward-looking  statements.  Readers are
referred to the documents  filed by the Company with the Securities and Exchange
Commission,  specifically  the Company's  definitive proxy statement on Schedule
14A filed on October 1, 2004 and the Company's  most recent reports on Form 10-K
and 10-Q.  The  information  in this  release  is current as of the date of this
release, but may not remain accurate as of any future date. The Company does not
undertake any duty to update or revise the information provided in this release,
except as otherwise required by law.


Contact:

   Milton "Todd" Ault III
   Chairman and Chief Executive Officer
   Franklin Capital Corporation
   Santa Monica, California 90401
   ph: (310) 752-1416

